This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fine, D P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fine, D P

 Previous Article  |  Next Article 

Infect Immun. 1975 October; 12(4): 772-778

Pneumococcal type-associated variability in alternate complement pathway activation.

D P Fine

ABSTRACT

Opsonization of Streptococcus pneumoniae may be mediated by the alternate complement pathway. To study the importance of this interaction to human disease, complement consumption by pneumococci of various serotypes was measured in humwn serum chelated with ethyleneglycoltraacetic acid, a substance that blocks the classic but not the alternate complement pathwway. Serotype I, in contrast to all other types studied, lacked ability to consume complement in this system. The ability for serotypes III, IV, and VIII to activate the alternate pathway could be eliminated by prior serum absorption at O C with they type in question, a condition that would remove antibody but not complement. Types VII, XII, XIV, and XXV readily activated the alternate pathway in unabsorbed and absorbed sera. Differences could not be related to properties of the capsules. It was concluded that types I, III, IV, and VIII lack intrinsic ability to activate and thus be opsonized by the alternate complement pathway, although types III, IV, and VIII can do so in concert with specific antibody. The fact that these same types are especially prominent in human disease suggests that the ability to evade opsonization by the alternate complement pathway in pre-antibody phases of infection may be a virulence factor in pneumococci.

Infect Immun. 1975 October; 12(4): 772-778




This article has been cited by other articles:

  • Sabharwal, V., Ram, S., Figueira, M., Park, I. H., Pelton, S. I. (2009). Role of Complement in Host Defense against Pneumococcal Otitis Media. Infect. Immun. 77: 1121-1127 [Abstract] [Full Text]  
  • Yuste, J., Sen, A., Truedsson, L., Jonsson, G., Tay, L.-S., Hyams, C., Baxendale, H. E., Goldblatt, F., Botto, M., Brown, J. S. (2008). Impaired Opsonization with C3b and Phagocytosis of Streptococcus pneumoniae in Sera from Subjects with Defects in the Classical Complement Pathway. Infect. Immun. 76: 3761-3770 [Abstract] [Full Text]  
  • Abeyta, M., Hardy, G. G., Yother, J. (2003). Genetic Alteration of Capsule Type but Not PspA Type Affects Accessibility of Surface-Bound Complement and Surface Antigens of Streptococcus pneumoniae. Infect. Immun. 71: 218-225 [Abstract] [Full Text]  
  • Magee, A. D., Yother, J. (2001). Requirement for Capsule in Colonization by Streptococcus pneumoniae. Infect. Immun. 69: 3755-3761 [Abstract] [Full Text]  
  • Neeleman, C., Geelen, S. P. M., Aerts, P. C., Daha, M. R., Mollnes, T. E., Roord, J. J., Posthuma, G., van Dijk, H., Fleer, A. (1999). Resistance to Both Complement Activation and Phagocytosis in Type 3 Pneumococci Is Mediated by the Binding of Complement Regulatory Protein Factor H. Infect. Immun. 67: 4517-4524 [Abstract] [Full Text]  
  • Zhong, Z., Burns, T., Chang, Q., Carroll, M., Pirofski, L. (1999). Molecular and Functional Characteristics of a Protective Human Monoclonal Antibody to Serotype 8 Streptococcus pneumoniae Capsular Polysaccharide. Infect. Immun. 67: 4119-4127 [Abstract] [Full Text]  
  • Janoff, E. N., Breiman, R. F., Daley, C. L., Hopewell, P. C. (1992). Pneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives. ANN INTERN MED 117: 314-324 [Abstract]  
  • Tunkel, A. R., Wispelwey, B., Scheld, W. M. (1990). Bacterial Meningitis: Recent Advances in Pathophysiology and Treatment. ANN INTERN MED 112: 610-623 [Abstract]  
  • WINSTON, D. J., SCHIFFMAN, G., WANG, D. C., FEIG, S. A., LIN, C.-H., MARSO, E. L., HO, W. G., YOUNG, L. S., GALE, R. P. (1979). Pneumococcal Infections After Human Bone-Marrow Transplantation. ANN INTERN MED 91: 835-841 [Abstract]  
  • Gopal, V., Bisno, A. L. (1977). Fulminant Pneumococcal Infections in 'Normal' Asplenic Hosts. Arch Intern Med 137: 1526-1530 [Abstract]  
  • COONROD, J. D., LEACH, R. P. (1976). Antigenemia in Fulminant Pneumococcemia. ANN INTERN MED 84: 561-563 [Abstract]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»